Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1996 1
2005 2
2007 2
2009 1
2010 1
2011 1
2012 2
2014 1
2015 1
2016 2
2017 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma"
Page 1
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management.
Chan Y, Fisher P, Tilki D, Evans CP. Chan Y, et al. BJU Int. 2016 Apr;117(4):563-9. doi: 10.1111/bju.13370. Epub 2015 Dec 12. BJU Int. 2016. PMID: 26556525 Review.
To summarise the current literature on the diagnosis and management of urethral recurrence (UR) after radical cystectomy (RC), as UR after RC is rare but associated with high mortality. ...A review of the PubMed database from 1980 to 2014 was performed to identify s …
To summarise the current literature on the diagnosis and management of urethral recurrence (UR) after radical cystectomy (RC), as UR …
Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F, Chebil G, Månsson W. Liedberg F, et al. Expert Rev Anticancer Ther. 2007 Mar;7(3):383-90. doi: 10.1586/14737140.7.3.383. Expert Rev Anticancer Ther. 2007. PMID: 17338657 Review.
We reviewed the literature on urothelial carcinoma in the prostatic urethra and prostate. We concluded that the incidence of urothelial carcinoma in the prostatic urethra and prostate is probably underestimated. ...At cystectomy, when urothelial
We reviewed the literature on urothelial carcinoma in the prostatic urethra and prostate. We concluded that the incidence of …
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.
Laukhtina E, Moschini M, Soria F, Andrea DD, Teoh JY, Mori K, Albisinni S, Mari A, Krajewski W, Cimadamore A, Abufaraj M, Enikeev D, Neuzillet Y, Giannarini G, Xylinas E, Kamat AM, Roupret M, Babjuk M, Witjes JA, Shariat SF, Pradere B; European Association of Urology; Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group; European Association of Urology Section of Oncological Urology ESOU. Laukhtina E, et al. Eur Urol Focus. 2022 Nov;8(6):1635-1642. doi: 10.1016/j.euf.2022.03.004. Epub 2022 Mar 23. Eur Urol Focus. 2022. PMID: 35337773 Free article. Review.
CONTEXT: Surveillance of the urethra and management of urethral recurrence (UR) after radical cystectomy (RC) is an area with poor evidence. ...According to the currently available literature, a tight-knitted surveillance protocol should be implemented for males treated wi …
CONTEXT: Surveillance of the urethra and management of urethral recurrence (UR) after radical cystectomy (RC) is an area with poor ev …
Palliative intralesional interleukin-2 treatment in dogs with urinary bladder and urethral carcinomas.
Konietschke U, Teske E, Jurina K, Stockhaus C. Konietschke U, et al. In Vivo. 2012 Nov-Dec;26(6):931-5. In Vivo. 2012. PMID: 23160674
AIM: The investigation of the influence of intralesional interleukin-2 (IL-2) on the clinical course and tumor progression in dogs suffering from urinary bladder and urethral carcinomas. ...CONCLUSION: Intralesional IL-2 application is a safe and minim …
AIM: The investigation of the influence of intralesional interleukin-2 (IL-2) on the clinical course and tumor progression in dogs su …
Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
Ng KL, Chua CB. Ng KL, et al. Asian J Surg. 2017 Apr;40(2):163-165. doi: 10.1016/j.asjsur.2014.01.016. Epub 2014 Aug 30. Asian J Surg. 2017. PMID: 25183290 Free article.
Intravesical Bacillus Calmette-Guerin (BCG) has been a proven and effective immunotherapy treatment for superficial transitional cell carcinoma (TCC) of the bladder, especially for high-grade tumors and carcinoma in situ. Nevertheless, significa …
Intravesical Bacillus Calmette-Guerin (BCG) has been a proven and effective immunotherapy treatment for superficial transitional c
Bladder cancer: current management and opportunities for a personalized approach.
Galsky MD, Hall SJ. Galsky MD, et al. Mt Sinai J Med. 2010 Nov-Dec;77(6):587-96. doi: 10.1002/msj.20224. Mt Sinai J Med. 2010. PMID: 21105122 Review.
Urothelial carcinoma of the bladder exists as a spectrum of clinical states ranging from non-muscle-invasive to muscle-invasive to advanced/metastatic disease. Each clinical state is associated with a unique tumor biology, p
Urothelial carcinoma of the bladder exists as a spectrum of clinical states ranging from non-muscle-invasive
Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS. Raman JD, et al. BJU Int. 2005 Nov;96(7):1031-5. doi: 10.1111/j.1464-410X.2005.05804.x. BJU Int. 2005. PMID: 16225523
OBJECTIVE: To evaluate patients with a history of transitional cell carcinoma (TCC) of the upper urinary tract (UUT) to determine the incidence, pathological distribution, and risk factors for developing subsequent bladder tumours. ...Neither th …
OBJECTIVE: To evaluate patients with a history of transitional cell carcinoma (TCC) of the upper urinary tract ( …
Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: A prospective, nonrandomized two-center trial with 36-month follow-up.
Chen J, Zhao Y, Wang S, Jin X, Sun P, Zhang L, Wang M. Chen J, et al. Lasers Surg Med. 2016 Nov;48(9):859-865. doi: 10.1002/lsm.22565. Epub 2016 Jul 25. Lasers Surg Med. 2016. PMID: 27454755 Clinical Trial.
OBJECTIVES: To evaluate the safety and efficacy of LBO laser en bloc resection compared with transurethral electroresection (TURBT) for the treatment of primary non-muscle-invasive bladder tumors. METHODS: From September 2010 to February 2012, a prospective, nonrand …
OBJECTIVES: To evaluate the safety and efficacy of LBO laser en bloc resection compared with transurethral electroresection (TURBT) for the …
Intravesical Bacillus Calmette-Guerin with the Danish strain for treatment of carcinoma in situ of the bladder.
Ovesen H, Poulsen AL, Steven K. Ovesen H, et al. Br J Urol. 1993 Nov;72(5 Pt 2):744-8. doi: 10.1111/j.1464-410x.1993.tb16260.x. Br J Urol. 1993. PMID: 8281407
Patients were considered treatment failures if they suffered progression to invasive cancer, metastasis or died from transitional cell carcinoma. ...All responded to BCG treatment; 2 suffered from recurrent CIS 1 associated with invasive
Patients were considered treatment failures if they suffered progression to invasive cancer, metastasis or died from transitional
Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin.
Hillyard RW Jr, Ladaga L, Schellhammer PF. Hillyard RW Jr, et al. J Urol. 1988 Feb;139(2):290-3. doi: 10.1016/s0022-5347(17)42389-5. J Urol. 1988. PMID: 3339727
Intravesical Pasteur strain bacillus Calmette-Guerin was used to treat 8 patients with mucosal transitional cell carcinoma of the prostatic urethra associated with superficial transitional cell carcinoma of the bladder. ...T …
Intravesical Pasteur strain bacillus Calmette-Guerin was used to treat 8 patients with mucosal transitional cell carcinoma
17 results